• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION PRISMAFLEX HF20; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION PRISMAFLEX HF20; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 109841
Medical Device Problem Code Obstruction of Flow (2423)
Health Effect - Clinical Code Appropriate Clinical Signs, Symptoms, Conditions Term / Code Not Available (4581)
Date of Event 08/08/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The associated lot numbers were 21a1203z and 21c1007z.Prismaflex hf20 set has been temporarily approved for use in the us under emergency use authorization (b)(4) to provide continuous renal replacement therapy (crrt) to treat low weight (8 kg to 20 kg) and low blood volume patients or patients who have acute renal failure, fluid overload, or both, and who cannot tolerate a larger extracorporeal circuit volume in an acute care environment during the coronavirus disease 2019 (covid-19) pandemic.Should additional relevant information become available, a supplemental report will be submitted.
 
Event or Problem Description
It was reported approximately 16 hours into a pediatric continuous renal replacement therapy (crrt) in hemodiafiltration (cvvhdf) mode (connected to extracorporeal membrane oxygenation circuit), with a prismaflex control unit and two (2) units of prismaflex hf20 clotted resulting in a blood loss.The amount of blood loss was not specified.Treatment was restarted two and a half hours later with a new prismaflex hf20.Nine hours into treatment, the filter clotted resulting in an unspecified amount of blood loss.Treatment was restarted again on a new prismaflex hf20.On the following day (the date of this event, reported as seventeen hours into treatment), the filter clotted resulting in an unspecified amount of blood loss.It was reported that the prismaflex control unit generated a malfunction: self-test failure code 2, code 4, and code 6 alarms.The patient required packed red blood cells transfusion for the event.The outcome was not reported.No additional information is available.
 
Additional Manufacturer Narrative
Additional information: h6 and h10.H10: a batch review was conducted and there were no deviations found related to this reported condition during the manufacture of this lot.The device was not received for evaluation; therefore, a device analysis could not be completed.Should additional relevant information become available, a supplemental report will be submitted.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PRISMAFLEX HF20
Common Device Name
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
deerfield IL
Manufacturer (Section G)
BAXTER HEALTHCARE - MEYZIEU
7, av lionel terray, b.p. 126
meyzieu cedex rhone 69883
FR   69883
Manufacturer Contact
25212 w. illinois route 120
round lake, IL 
2242702068
MDR Report Key12508078
Report Number8010182-2021-00277
Device Sequence Number12487407
Product Code KDI
Combination Product (Y/N)Y
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
NA
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 11/15/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue Number109841
Device Lot NumberASKU
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Initial
Initial Date Received by Manufacturer 08/24/2021
Supplement Date Received by Manufacturer10/20/2021
Initial Report FDA Received Date09/21/2021
Supplement Report FDA Received Date11/15/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Unknown
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
PRISMAFLEX CONTROL UNIT; PRISMAFLEX CONTROL UNIT
Outcome Attributed to Adverse Event Required Intervention;
Patient Age2 YR
Patient SexMale
Patient Weight10 KG
-
-